Mitarbeitende
![Instituts für Life Sciences : Experten in angewandter Forschung, Dienstleistungen und Weiterbildung. Unsere interdisziplinären Teams arbeiten mit der Industrie zusammen, um innovative und nachhaltige Lösungen anzubieten. 90 Mitarbeiter, hochmoderne Infrastruktur, über 200 Projekte pro Jahr in Pharmazie, Biopharmazie, Umwelt, Biotechnologie, Diagnostik, Lebensmittelwissenschaften, Chemie.](/media/image/21/xlarge_2_1/life-technolgies.jpg?4f669bb961c3e92f60b802b35d069e43)
Funktion | Professor/in FH |
---|---|
Ausbildungen | Chimiste, Dr |
Telefon | |
marc.mathieu@hevs.ch | |
Büro | ENP 19.N304 |
Dr. Mathieu has over 20 years of experience in the Peptide drug discovery field, mainly focusing on peptide chemoselective conjugation, peptidic linkers, branched peptides and peptidomimetics. He worked for 10 years in the peptide pharma industry with responsibilities in custom manufacturing, investigation of novel synthetic routes (creating IP value) and all related analytical/scale-up processes.
Dr. Mathieu gives lectures in Chemistry and biochemistry. He is a member of the Peptide and Protein Technology research group and his current responsibilities include the state-of-the art peptide laboratory.
Find in section "Documents" the presentation of our Peptide & Peptidomimetics Platform
Representative Projects
Representative Publications (co-author)